Health

MIT researchers have developed an AI system that can predict Alzheimer’s risk by forecasting how patients will perform on a test measuring cognitive decline up to two years in advance, reports Casey Ross for STAT. 

A new MIT study shows that “China’s move away from fossil fuels would mean 2,000 fewer premature deaths in the U.S. by 2030,” reports John Fialka for E&E News. "It reminds us that air pollution doesn't stop at national boundaries," said Prof. Valerie Karplus, a co-leader of the paper. 

President Emerita Susan Hockfield discusses her new book, “The Age of Living Machines,” her work as a neuroscientist, and the future of science and technology during a curated lunch conversation with HUBweek and Boston.com. Hockfield explains that a revolution spurred by the convergence of biology with engineering will lead to new technologies built by biology.

Writing for Times Higher Education, senior lecturer Anjali Sastry argues that entrepreneurship is a key component in finding solutions to complex global health problems. Sastry spotlights how MIT students are provided with hands-on opportunities to “learn analytics, systems thinking, effective business models and entrepreneurial processes. They aren’t just learning how to maximize profits, but ways to understand the market and craft systems.”

In an excerpt from her new book published in The Wall Street Journal, President Emerita Susan Hockfield explores how the convergence between biology and engineering is driving the development of new tools to tackle pressing human problems. Hockfield writes that for these world-changing technologies to be realized requires “not only funding and institutional support but, more fundamentally, a commitment to collaboration among unlikely partners.”

President Emerita Susan Hockfield speaks with Jim Braude of WGBH’s Greater Boston about her book, “The Age of Living Machines.” “We are looking at a population of over 9.7 billion by 2050,” explains Hockfield. “We are not going to get there without war or epidemics or starvation if we don’t develop technologies that will allow us to provide energy, food, water, health and health care sustainably.”

MIT researchers have found that tracking specific changes in the number of chromosomes inside prostate cancer cells might help determine whether tumors should be treated, reports Robert Preidt for HealthDay News. “Besides giving new insights into how prostate tumors form and spread, the chromosomal data might someday be employed clinically to inform risk stratification and treatment decisions,” Preidt explains.

Boston Globe reporters Ysabelle Kempe and Felice Freyer write that MIT is launching a new Down syndrome research center with a gift from the Alana Foundation. “I really want people with different conditions and different ability to feel they are not different, to feel that they belong, and to enhance their capability to interact and to enjoy life,” explains Prof. Li-Huei Tsai.

MIT is launching a new Down syndrome research center thanks to a gift from the Alana Foundation, reports the AP. The center “will combine the expertise of scientists and engineers in an effort to increase understanding of the biology and neuroscience of Down syndrome.”

MIT researchers have found that some inactive ingredients in medications could play a role in triggering irritation or allergic reactions, reports Bob McDonald for CBC Radio. The researchers hope that, “pharmaceutical companies provide more information to doctors, and that alternative drug formulas can be developed for people with allergies or sensitivities.”

Prof. Giovanni Traverso speaks with STAT reporter Shraddha Chakradhar about a study examining how the inactive substances in most medications could trigger a patient’s allergies and intolerances. “As you start taking more and more tablets, then you are also taking more and more of some of these ingredients,” says Traverso. “We want to raise awareness that these ingredients are there.”

NBC News reporter Linda Caroll writes about a new study by MIT researchers showing that inactive ingredients in medications could lead to adverse reactions in some patients. The researchers found that some of the inactive ingredients “can worsen symptoms in people with conditions such as irritable bowel syndrome, or IBS.”

Gizmodo reporter Ed Cara writes about a study by MIT researchers have finds “inactive” ingredients in pills could trigger a patient’s allergies or intolerances. “We’re not saying that everyone should stop taking these medications,” explains Prof. Giovanni Traverso. “But people with an allergy or intolerance should definitely have the opportunity to find out if they have to worry about certain medications.”

MIT researchers have found that many pills contain “inactive” ingredients that could be troublesome for patients, reports Richard Harris for NPR. Prof. Giovanni Traverso explains that if a patient with lactose intolerance takes a pill containing lactose, “it's probably not going to manifest in any significant symptoms. But as the number of pills you're taking [increases], then certainly you might cross that threshold."

AP reporter Lauran Neergaard writes that a new study by MIT researchers finds that pills often contain “inactive” ingredients capable of causing allergic or gastrointestinal reactions. The researchers found that “it’s hard for those patients, or even their doctors, to tell if a pill contains an extra ingredient they should avoid,” Neergaard explains.